跳至主要内容
临床试验/NCT07312383
NCT07312383招募中不适用

Skin Microcirculation in Patients With Lower Limb Atherosclerosis

ODI Medical AS1 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2025年12月15日最近更新:

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
30
试验地点
1
主要终点
Changes in skin microvascular oxygen saturation (SmvO2)

研究概览

简要总结

The aim of this study is to explore the ability of the non-invasive device ODI-Tech® to monitor changes in microvascular blood flow in patients with lower limb ischemia undergoing the procedure percutaneous transluminal angioplasty (PTA). Microvascular data from patients and healthy case matched controls at baseline will be compared.15 patients and 15 healthy case matched controls will be enrolled.

详细描述

This clinical investigation is designed as a prospective study of limb skin nutritive capillary perfusion and oxygen extraction in patients with lower limb atherosclerosis and severe symptoms before and following elective PTA.

15 patients with critical lower limb atherosclerosis and ischemia in Rutherford grade 3 - 6 undergoing PTA, as well as 15 healthy case matched controls will be enrolled. Measurements will be performed at baseline, prior to PTA, immediately after PTA, 1 day and 30 days post PTA. Healthy case matched controls will be measured at baseline.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Lower limb atherosclerosis and ischemia in Rutherford grade 3-6
  • Obstructive infra-inguinal arterial lesions combined with open distal part of the anterior tibial artery
  • Scheduled for elective PTA
  • Able to give informed consent

排除标准

  • Active skin infection at the region of interest (site to be examined, dorsum of hand and foot)

结局指标

主要结局

Changes in skin microvascular oxygen saturation (SmvO2)

时间窗: From baseline to 40 days post PTA

Changes in functional Capillary Density (FCD)

时间窗: From baseline to 40 days post PTA.

次要结局

  • Incidence of AE/ADE/SAE/SADE/DD(From baseline to 40 days post PTA)

研究者

发起方
ODI Medical AS
申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验